Kate McKenney, a counsel in the firm’s Complex Litigation & Dispute Resolution practice, is a member of the firm’s Life Sciences Disputes group and focuses her practice on representing public companies in the life sciences, biotechnology, and medical device industries, and their officers and directors, in securities class action and derivative litigation. Ms. McKenney also represents clients in ERISA and mutual fund class action litigation, fiduciary duty and corporate governance matters, post-closing disputes, and investigations by various government and regulatory entities including the U.S. Securities and Exchange Commission, the U.S. Department of Justice, and the U.S. Department of Labor.
Ms. McKenney works with clients at all phases of litigation, advising clients on disclosure-related issues, litigation risk mitigation measures, and discovery, and has participated in the negotiation of favorable settlements.
Ms. McKenney's practice includes defense of companies and individuals in securities class action lawsuits, derivative litigation, and a variety of other complex business litigation matters. She has also worked on both internal and governmental investigations concerning federal securities laws and accounting issues.
Ms. McKenney is a member of the Boston Bar Association, Massachusetts Bar Association and American Bar Association.
Prior to joining Goodwin in 2008, Ms. McKenney was an associate in the Boston office of Bingham McCutchen.
Boston College Law School
(magna cum laude, Order of the Coif)
- U.S. District Court for the District of Massachusetts
- U.S. District Court for the Eastern District of Michigan
- U.S. Court of Appeals for the Ninth Circuit
Recognition & Awards
While attending law school, Ms. McKenney was an articles editor for the Boston College Law Review.